GLSI

Greenwich Lifesciences Inc

NASDAQ: GLSI · HEALTHCARE · BIOTECHNOLOGY

$18.31

+5.11% today

Updated 2026-10-28

Market cap

$227.22M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.53

Dividend yield

—

52W range

$8 – $34

Volume

0.1M

Market cap

$227.22M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.53

Dividend yield

—

52W range

$8 – $34

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.3

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-30.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →270 stocks currently score above 75

Price targets

Analyst target

$57.00

+211.31%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -29.98 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.94M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-7.83M	$-8.89M	$-17.41M	$-19.36M	$-3.95M
EPS	—	—	—	—	$-1.53
Free cash flow	$-6.20M	$-6.48M	$-7.27M	$-9.91M	$-1.94M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-01-13	PATEL, SNEHAL	Buy	1,800	$29.83
2026-01-12	PATEL, SNEHAL	Buy	2,900	$27.54
2025-12-31	PATEL, SNEHAL	Buy	4,300	$21.36

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GLSI	$227.22M	16	4.3	3.0	5.0	4.3	—	Avoid
LLY	$1.12T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$615.87B	57	4.7	8.5	2.7	5.5	-83.05%	Buy
ABBV	$504.37B	73	6.7	8.5	4.0	5.0	-86.73%	Strong Buy
UNH	$360.32B	62	6.7	6.0	4.7	5.5	-25.92%	Buy
MRK	$360.08B	36	4.0	4.5	2.0	5.0	-73.68%	Hold

Smart narrative

Greenwich Lifesciences Inc trades at $18.31. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -29.98, it sits in the distress.

Frequently asked questions

What is Greenwich Lifesciences Inc's stock price?

Greenwich Lifesciences Inc (GLSI) trades at $18.31.

Is Greenwich Lifesciences Inc overvalued?

Greenwich Lifesciences Inc carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Greenwich Lifesciences Inc (GLSI)?

The 12-month analyst consensus target is $57.00, about 211.3% above the current $18.31. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Greenwich Lifesciences Inc's Altman Z-Score is -29.98, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

greenwichlifesciences.com

Quick metrics

P/S ratio—

ROE-6.77%

Beta1.46

50D MA$16.66

200D MA$21.80

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GLSI vs LLY →GLSI vs JNJ →GLSI vs ABBV →Stock screener →